STOCK TITAN

Voyager Therapeutics, Inc. - $VYGR STOCK NEWS

Welcome to our dedicated page for Voyager Therapeutics news (Ticker: $VYGR), a resource for investors and traders seeking the latest updates and insights on Voyager Therapeutics stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Voyager Therapeutics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Voyager Therapeutics's position in the market.

Rhea-AI Summary
Voyager Therapeutics to participate in investor conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.8%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.92%
Tags
management
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.44%
Tags
-
Rhea-AI Summary
Voyager Therapeutics to participate in Fireside Chat at Canaccord Genuity Annual Growth Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.17%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.37%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.32%
Tags
none
-
Rhea-AI Summary
Voyager Therapeutics appoints Jacquelyn Fahey Sandell as Chief Legal Officer
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
management
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.17%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.16%
Tags
conferences
Voyager Therapeutics, Inc.

Nasdaq:VYGR

VYGR Rankings

VYGR Stock Data

466.11M
36.94M
17.29%
49%
6.13%
Biological Product (except Diagnostic) Manufacturing
Manufacturing
Link
United States of America
LEXINGTON

About VYGR

voyager therapeutics is a gene therapy company developing life-changing treatments for fatal and debilitating diseases of the central nervous system (cns). voyager is committed to advancing the field of aav (adeno-associated virus) gene therapy through innovation and investment in vector optimization and engineering, dosing techniques, as well as process development and production. the company’s initial pipeline is focused on cns diseases in dire need of effective new therapies, including parkinson’s disease, a monogenic form of amyotrophic lateral sclerosis (als), and friedreich’s ataxia. founded by scientific and clinical leaders in the fields of aav gene therapy, expressed rna interference and neuroscience, voyager therapeutics was launched in 2014 with funding from leading life sciences investor third rock ventures and is headquartered in cambridge, mass. for more information, please visit www.voyagertherapeutics.com.